- Jan 25, 2023
- Fujifilm Completes Asset Purchase Agreement of Inspirata, Inc.’s Digital Pathology Business
- Dec 19, 2022
- Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
- Aug 30, 2022
- FUJIFILM Sonosite brings on Industry Leader Richard Kelly as VP of R&D
- Jun 30, 2022
- Richard Fabian Named Chief Executive Officer of FUJIFILM Sonosite
- May 16, 2022
- FUJIFILM VisualSonics Launches the New Multi-modal Vevo F2 Imaging Platform for Preclinical Ultrasound
- Apr 18, 2022
- FUJIFILM Sonosite announces the availability of Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system, in Canada
- Feb 10, 2022
- FUJIFILM VisualSonics and PIUR IMAGING Partner to Enable Ultra-High Frequency, 3D Ultrasound Imaging Technology
- Oct 14, 2021
- Fujifilm’s ASPIRE Cristalle Digital Mammography System Receives Health Canada Medical Device Licence
- Mar 10, 2021
- Fujifilm Sonosite Launches New Point-of-Care Ultrasound System with Adaptable Form Factor, Embedded Workflow, and the Most Advanced Image Clarity Sonosite Has Ever Offered
- Apr 15, 2020
- Fujifilm accelerates production of its influenza antiviral drug “Avigan® Tablet” for COVID-19
- Apr 9, 2020
- Fujifilm announces the start of a phase II clinical trial of its influenza antiviral drug “Avigan® Tablet” for COVID-19 patients in the U.S.
- Mar 31, 2020
- FUJIFILM ANNOUNCES THE START OF A PHASE III CLINICAL TRIAL OF INFLUENZA ANTIVIRAL DRUG “AVIGAN TABLET” ON COVID-19 AND COMMITS TO INCREASING PRODUCTION
Cookies are important to the proper functioning of a site. To improve your experience, we use cookies to remember log-in details and provide secure log-in, collect statistics to optimize site functionality and deliver content tailored to your interest.
By continuing to use this site you are giving us your consent to do this. For more information you can read our Privacy Policy.